Circ Arrhythm Electrophysiol

Slides:

Advertisements

Similar presentations

Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mechanical Dispersion Assessed by Myocardial Strain.

Advertisements

A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart.

Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Predictors of Implantable Cardioverter-Defibrillator.

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy? Wayne C. Levy,

Copyright © 2002 American Medical Association. All rights reserved.

Heart, Lung and Circulation

Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score

Severe Mitral Regurgitation at Time of Left Ventricular Assist Device Implantation - Comparison of Systematic Mitral Valve Repair vs Surgical Abstention

Circ Cardiovasc Imaging

Cardiac Resynchronization Therapy Using Quadripolar Versus Non‐Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single‐Site Left.

Spontaneous Coronary Artery Dissection

Circ Arrhythm Electrophysiol

by Alexander Kulik, Ian G. Burwash, Varun Kapila, Thierry G

Circ Arrhythm Electrophysiol

Circ Arrhythm Electrophysiol

Circ Arrhythm Electrophysiol

Slowing of ventricular rate (VR) associated with inferior vena cava–inferior atrial ganglionated plexus nerve activity (IVC-IAGPNA) discharge without right.

Blood Pressure and Adverse Events During Continuous Flow Left Ventricular Assist Device SupportCLINICAL PERSPECTIVE by Omar Saeed, Rita Jermyn, Faraj Kargoli,

Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic DysfunctionClinical Perspective.

Optimal Pacing for Right Ventricular and Biventricular Devices

by Peter J. Schwartz, Maria Teresa La Rovere, Gaetano M

Volume 13, Issue 1, Pages (January 2016)

Volume 5, Issue 4, Pages (April 2008)

José L. Morales et al. JACEP 2017;j.jacep

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Volume 8, Issue 5, Pages (May 2011)

Volume 68, Issue 2, Pages (August 2005)

Laura Harvey, MD, Christopher Holley, MD, Samit S

Gaurav A. Upadhyay, MD, Jonathan S. Steinberg, MD Heart Rhythm

David D. Berg et al. JACC 2018;71:

Misconceptions and Facts About Hypertrophic Cardiomyopathy

Angelo Auricchio, and Frits W. Prinzen JACEP 2017;3:

Direct aortic transcatheter aortic valve implantation for pure aortic valve regurgitation after implantation of a left ventricular assist device René.

Surgery for Ventricular Tachycardia in Patients Undergoing Left Ventricular Reconstruction by the Dor Procedure Ulrik Sartipy, MD, Anders Albåge, MD,

Belinda Gray et al. JCHF 2013;1:

David F. Katz et al. JACEP 2016;j.jacep

Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.

Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices Ranjit John, MD, Kenneth Liao,

Volume 11, Issue 2, Pages (February 2014)

Volume 15, Issue 10, Pages e253-e274 (October 2018)

Volume 11, Issue 2, Pages (February 2014)

Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes

Prabhat Kumar et al. JACEP 2016;j.jacep

Ethnic and racial disparities in cardiac resynchronization therapy

Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa.

Angelo Auricchio, and Frits W. Prinzen JACEP 2017;j.jacep

Prabhat Kumar et al. JACEP 2016;j.jacep

Volume 7, Issue 7, Pages (July 2010)

David F. Katz et al. JACEP 2017;3:20-28

Volume 7, Issue 3, Pages (March 2010)

Jerry D. Estep et al. JCHF 2013;1:

Volume 15, Issue 1, Pages (January 2018)

Volume 11, Issue 3, Pages (March 2014)

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep

James O. O’Neill, MB, Randall C

Trends in LVAD implantation rates among the Medicare population from 2004 to Trends in LVAD implantation rates among the Medicare population from.

Jay K. Bhama, MD, Utsav Bansal, BS, Daniel G. Winger, MS, Jeffrey J

Alcoholic Cardiomyopathy and Ventricular Arrhythmias

Saadia Sherazi et al. JACEP 2015;1:74-80

Preemptive Axillo-Axillary Placement of Percutaneous Transseptal Ventricular Assist Device to Facilitate High-Risk Reoperative Cardiac Surgery Anelechi.

Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices Simon.

A and B, The ROC curves analyzing the sensitivity and specificity of the WHO grading system (I-IV) for the 1-year survival (A) and recurrence (B) show.

Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.

Survival of subjects listed for heart transplantation with and without spirometry. Survival of subjects listed for heart transplantation with and without.

Volume 16, Issue 6, Pages (June 2019)

(A). (A). Kaplan-Meier plot of event-free survival in 27 LMNA mutation carriers and 78 DCM control patients. Death, heart transplantation, resuscitation.

Survival free of atrial fibrillation after implantation of an implantable cardioverter defibrillator in our series (151 patients): overall population (solid.

Presentation transcript:

Circ Arrhythm Electrophysiol The Role of Implantable Cardioverter-Defibrillators in Patients With Continuous Flow Left Ventricular Assist DevicesClinical Perspective by Alan D. Enriquez, Brandon Calenda, Marc A. Miller, Anelechi C. Anyanwu, and Sean P. Pinney Circ Arrhythm Electrophysiol Volume 6(4):668-674 August 20, 2013 Copyright © American Heart Association

Copyright © American Heart Association

Copyright © American Heart Association

Copyright © American Heart Association

Copyright © American Heart Association

Copyright © American Heart Association

Copyright © American Heart Association

Kaplan–Meier survival curves of patients with the HeartMate II according to post–left ventricular assist device ventricular arrhythmias (VA; A) and implantable cardioverter-defibrillator (ICD) status (B); n=98. Kaplan–Meier survival curves of patients with the HeartMate II according to post–left ventricular assist device ventricular arrhythmias (VA; A) and implantable cardioverter-defibrillator (ICD) status (B); n=98. CI indicates confidence interval. Enriquez A et al. Circ Arrhythm Electrophysiol 2013;6:668-674 Copyright © American Heart Association